US BANCORP \DE\ - TANDEM DIABETES CARE INC ownership

TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 299 filers reported holding TANDEM DIABETES CARE INC in Q4 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of TANDEM DIABETES CARE INC
ValueSharesWeighting
Q3 2023$234,617
-11.5%
11,296
+4.6%
0.00%
Q2 2023$264,983
-41.6%
10,798
-3.3%
0.00%
-100.0%
Q1 2023$453,532
-9.1%
11,168
+0.7%
0.00%0.0%
Q4 2022$498,675
-21.7%
11,094
-16.9%
0.00%0.0%
Q3 2022$637,000
+6.7%
13,344
+32.8%
0.00%0.0%
Q2 2022$597,000
-51.4%
10,049
-4.9%
0.00%
-50.0%
Q1 2022$1,229,000
-16.0%
10,569
+8.8%
0.00%0.0%
Q4 2021$1,463,000
+32.6%
9,716
+5.2%
0.00%0.0%
Q3 2021$1,103,000
+108.5%
9,239
+70.2%
0.00%
+100.0%
Q2 2021$529,000
+41.1%
5,427
+27.7%
0.00%0.0%
Q1 2021$375,000
+393.4%
4,249
+434.5%
0.00%
Q4 2020$76,000
-1.3%
795
+16.4%
0.00%
Q3 2020$77,000
+22.2%
683
+7.9%
0.00%
Q2 2020$63,000
-28.4%
633
-53.6%
0.00%
Q1 2020$88,000
+25.7%
1,364
+17.2%
0.00%
Q4 2019$70,000
+105.9%
1,164
+101.0%
0.00%
Q3 2019$34,000
-87.0%
579
-85.7%
0.00%
-100.0%
Q2 2019$262,000
+26.0%
4,058
+23.6%
0.00%0.0%
Q1 2019$208,000
+49.6%
3,283
-9.9%
0.00%
Q4 2018$139,000
+29.9%
3,645
+46.4%
0.00%
Q3 2018$107,000
+872.7%
2,489
+397.8%
0.00%
Q2 2018$11,0005000.00%
Other shareholders
TANDEM DIABETES CARE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 474,929$22,725,0003.92%
Soleus Capital Management, L.P. 415,200$19,867,0002.70%
First Light Asset Management, LLC 485,620$23,237,0002.35%
Eagle Health Investments LP 196,400$9,398,0002.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 218,049$10,434,0001.66%
EMINENCE CAPITAL, LP 1,590,787$76,119,0001.59%
Brown Capital Management 2,010,230$96,190,0001.35%
Chicago Capital, LLC 479,873$22,962,0001.33%
Intrinsic Edge Capital Management LLC 247,391$11,838,0001.29%
Bellevue Group AG 1,566,015$74,933,0001.08%
View complete list of TANDEM DIABETES CARE INC shareholders